8732
S. L. Jain et al. / Tetrahedron Letters 45 (2004) 8731–8732
3
R
R1
R2
R1
R2
R3
H2O2/HBr (20 mol%), Chloramine-T
CH3CN, MgSO4, N2
4
R4
R
N
Ts
Scheme 1.
Vol. 42, Part 1, pp 1–214; (b) Padwa, A.; Woolhouse, A.
D. Aziridines and Fused Ring Derivatives. In Comprehen-
sive Heterocyclic Chemistry; Lwowski, W., Ed.; Pergamon:
Oxford, 1984; Vol. 7, pp 47–93.
H2O2
HBr
+
HOBr
C
C
1
2. (a) Padwa, A.; Woolhouse, A. D. In Comprehensive
Heterocyclic Chemistry: The Structure, Reactions, Synthe-
sis and Uses of Heterocyclic Compounds; Katritzky, A. R.,
Rees, C. W., Eds.; Pergamon Press: Oxford, 1984; Vol. 7,
p 47; (b) Kemp, J. E. In Comprehensive Organic Synthesis;
Trost, B. M., Fleming, I., Eds.; Pergamon: Oxford, 1991;
Vol. 7, p 469.
+
Br
C
C
Br
2
3. Yamada, Y.; Yamamoto, T.; Okawara, M. Chem. Lett.
1975, 361–362.
Cl
Ts
-
Br
Cl
N
4. (a) Evans, D. A.; Faul, M. M.; Bilodeau, M. T. J. Org.
Chem. 1991, 56, 6744–6746; (b) Evans, D. A.; Faul, M.
M.; Bilodeau, M. T.; Anderson, B. A.; Barnes, D. M. J.
Am. Chem. Soc. 1993, 115, 5328–5329; (c) Li, Z.; Conser,
K. R.; Jacobsen, E. N. J. Am. Chem. Soc. 1993, 115, 5326–
5327; (d) Evans, D. A.; Faul, M. M.; Bilodeau, M. T. J.
Am. Chem. Soc. 1994, 116, 2742–2753; (e) Llewellyn, D.
B.; Adamson, D. M.; Amdtsen, B. A. Org. Lett. 2000, 2,
4165–4168; (f) Muller, P.; Fruit, C. Chem. Rev. 2003, 103,
2905–2920; (g) Dauban, P.; Dodd, R. H. Synlett 2003,
1571–1586.
Br
C
-
-
OH
C
Br
C
C
N
N - Ts
4
Ts
Cl
3
C
N
C
-
Br
+
5. Simkhovich, L.; Gross, Z. Tetrahedron Lett. 2001, 42,
8089–8092.
Ts
Scheme 2.
6. (a) Ando, T.; Minakata, S.; Ryu, I.; Komatsu, M.
Tetrahedron Lett. 1998, 39, 309–312; (b) Vyas, R.;
Chanda, B. M.; Bedekar, A. W. Tetrahedron Lett. 1998,
39, 4715–4716; (c) Brandt, P.; Sodergren, M. J.; Anderson,
P. G.; Norrby, P.-O. J. Am. Chem. Soc. 2000, 122, 8013–
8020; (d) Albone, D. P.; Aujla, P. S.; Taylor, P. C.;
Challenger, S.; Derrick, A. M. J. Org. Chem. 1998, 63,
9569–9571; (e) Ando, T.; Kano, D.; Minakata, S.; Ryu, I.;
Komatsu, M. Tetrahedron 1998, 54, 13485–13494.
7. Jeong, J. U.; Tao, B.; Sagasser, I.; Henniges, H.;
Sharpless, K. B. J. Am. Chem. Soc. 1998, 120, 6844–
6845.
8. Ali, S. I.; Nikalje, M. D.; Sudalai, A. Org. Lett. 1999, 1,
705–707.
9. Thakur, V. V.; Sudalai, A. Tetrahedron Lett. 2003, 44,
989–992.
10. Daniel, R. B.; de Visser, S. P.; Shaik, S.; Neumann, R. J.
Am. Chem. Soc. 2003, 125, 12116–12117.
11. Typical experimental procedure: To a stirred solution of
hydrogen peroxide (aq 30%, 0.023ml, 20mol%) in aceto-
nitrile (5ml) was added hydrobromic acid (48%, 0.033ml,
20mol%), 4-methylstyrene (118mg, 1mmol), Chloramine-
T trihydrate (337mg, 1.2mmol) and MgSO4 (100mg)
under a nitrogen atmosphere at 25°C. Stirring was
continued for 3.5h and the reaction progress was moni-
tored by TLC (SiO2) using ethyl acetate/hexane (4:6) as
eluent. After completion, the solvent was evaporated
under reduced pressure. The residue obtained was purified
through a short silica gel column using hexane/ethyl
acetate (4:1) as eluent. Evaporation of the solvent yielded
benzene ring were found to be more reactive. The pres-
ence of a water-trapping agent was found to be essential
for this reaction as in its absence, lower yields of aziri-
dines were obtained.
Although the mechanism of this reaction is not clear at
this stage, the reaction probably involves the formation
of hypobromous acid by the reaction of aq hydrogen per-
oxide with hydrobromic acid, which acts as a source of
bromonium ions. The bromonium ion reacts with olefin
1 to afford intermediate 2, which undergoes ring opening
by Ts(Cl)NÀ to give b-bromo-N-chloro-p-toluenesulfon-
amide 3. Attack of OHÀ on the N–Cl group of presumed
intermediate 3 generates the anion 4 subsequent cycliza-
tion of which yields the aziridine (Scheme 2).7
Acknowledgements
We thank the Director, IIP, for his kind permission to
publish these results. S.L.J. and V.B.S. thank CSIR,
New Delhi, for the award of Research Fellowships.
References and notes
N-(p-tolylsulfonyl)-2-(p-methylphenyl)aziridine
(yield
1. (a) Deyrup, J. A. In The Chemistry of Heterocyclic
Compounds; Hassner, A., Ed.; Wiley: New York, 1983;
247mg, 80%). Similarly, other aziridines were prepared
via this procedure.